These outcomes, along with a prior report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 guidance the concept of targeting ACKR3 as a unique solution to modulate the opioid process, which could open new therapeutic avenues for opioid-associated disorders. Morphine and various opioids improve the https://klausl692fgw3.blogars.com/profile